Navigation Links
MP3 headphones interfere with implantable defibrillators, pacemakers
Date:11/9/2008

Headphones for MP3 players placed within an inch of pacemakers and implantable cardioverter defibrillators (ICDs) may interfere with these devices, according to research presented at the American Heart Association's Scientific Sessions 2008.

Researchers investigated the effects of MP3 player headphones, most of which contain the magnetic substance neodymium, on the operation of implanted cardiac devices (abstract P662).

An MP3 player is a popular digital music player. Earlier this year an FDA report concluded that interactions between MP3 players, such as the popular iPod, and implanted cardiac devices are unlikely to occur.

"We became interested in knowing whether the headphones which contain magnets not the MP3 players, themselves would interact with implanted cardiac devices," said William H. Maisel, M.D., M.P.H., senior author of the study and director of the Medical Device Safety Institute at Beth Israel Medical Center in Boston, Mass. Maisel said doctors traditionally use magnets in the clinical setting to test pacemakers, which treat slow heart rhythms. When exposed to magnets, these devices automatically pace, sending low-energy signals to the heart to make it beat. Defibrillators, which treat slow and dangerously fast heart rhythms, send either low- or high-energy signals to the heart. However, ICDs near magnets may temporarily stop looking for abnormal heart rhythms. Implanted cardiac devices that react in these ways to magnets outside the clinical setting can be potentially dangerous for patients who rely on their lifesaving technologies.

Researchers tested eight different models of MP3 player headphones (including both the clip-on and earbud variety) with iPods on 60 defibrillator and pacemaker patients.

"We placed the headphones on the patients' chests, directly over where their devices are located, monitoring them for evidence of an interaction," Maisel said.

The researchers found a detec
'/>"/>

Contact: AHA News Media Staff Office
karen.astle@heart.org
504-670-6524
American Heart Association
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Keystone Dental to Pay Nobel Biocare $2 Million to Settle Unfair Competition, Trade Secret Violations, and Tortious Interference Lawsuit
2. Study Published in JAMA on RFID Interference Ignores Real-World Use Cases, According to SkyeTek
3. IPods Dont Interfere With Pacemakers, Study Shows
4. IPods Dont Interfere With Heart Pacemakers
5. SuperArray Bioscience Corporation Licenses RNA Interference Patent From The Carnegie Institution
6. Abnormal glutamine repeats interfere with key transcription factor, leading to neurodegeneration
7. Stress and Anxiety Interfere With Sleep
8. Cancer Doctors Across America Stunned at Governments Ruling Restricting Anemia Management Protocols for Cancer Patients, Call Ruling Interference in Practice of Medicine
9. Long-Term Results of VisionCares Implantable Telescope for End-Stage Macular Degeneration Published in the American Journal of Ophthalmology
10. Texcel Introduces Innovative Programmable, Implantable Stimulation System for R&D of Specialty Stimulation Therapies
11. Northwestern Memorial trials implantable device to manage congestive heart failure symptoms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2014)... Mass., (PRWEB) September 01, 2014 BCC ... BLOOD-BRAIN BARRIER TECHNOLOGIES AND GLOBAL MARKETS , ... $21.8 million in 2013 and is expected to reach ... grow to $471.5 million by 2019, which is equivalent ... through 2019. The receptor-mediated transport (RMT) segment is forecasted ...
(Date:9/1/2014)... NJ (PRWEB) September 01, 2014 Registration is ... The Warriors® 5K and 1-Mile Race to be held on ... The Plaza Court Yard at Harmon Meadow in Secaucus, New ... The Warriors®, a national nonprofit dedicated to restoring a sense ... our service members and our military families. , General registration ...
(Date:9/1/2014)... Outlier Series announced the next short e-Book to be ... the exceptional women featured in the series’ third book, ... title of the upcoming mini e-Book is Ingredients ... is currently a full-time physician’s assistant, and mother of ... Raising Sextuplets. , Jenny was chosen as an outlier ...
(Date:9/1/2014)... (PRWEB) September 01, 2014 Beginning Tuesday, ... over 3,000 medical professionals and 10,000 consumers for the ... a 5-day gathering of the nation’s top medical professionals ... diseases or conditions. The week-long event contains more than ... scientific instruction available in the pain management field. , ...
(Date:8/31/2014)... Washington, D.C.USA (PRWEB) August 31, 2014 ... the global community utilizing social media marketing tools ... and interactive programs. MMU will utilize all tools ... become learning partner for our multiple learning channels. ... new mobile app, and an authoring tool that ...
Breaking Medicine News(10 mins):Health News:Global Market for Blood-Brain Barrier (BBB) Technology to Reach $471.5 Million in 2019; Highest CAGR Growth in Latin American Market With 10.5% 2Health News:Global Market for Blood-Brain Barrier (BBB) Technology to Reach $471.5 Million in 2019; Highest CAGR Growth in Latin American Market With 10.5% 3Health News:Hope For The Warriors New Jersey Run to Honor Wounded and Families of the Fallen 2Health News:Upcoming Outlier Series eBook about Jenny McClendon, PA-C, Former Start of Raising Sextuplets 2Health News:Upcoming Outlier Series eBook about Jenny McClendon, PA-C, Former Start of Raising Sextuplets 3Health News:Medical Marijuana Doctor Company Set to Present at Las Vegas Pain Week 2Health News:My Mobile University Announces Global Strategic Plan and Unveils New Android App to Enhance and Impact Lives World-Wide Through Education for All as Learning Platform 2Health News:My Mobile University Announces Global Strategic Plan and Unveils New Android App to Enhance and Impact Lives World-Wide Through Education for All as Learning Platform 3
... recently introduced at the Summer American Academy ... the treatment of mild-to-moderate atopic dermatitis in ... the marketers of Locoid Lipocream (hydrocortisone butyrate ... recently launched the new product to cover ...
... evidence that some people with HIV who for years and ... their blood never progress to full-blown AIDS and remain symptom ... strength of their immune systems, not any defects in the ... , Their conclusions about so-called elite suppressors, published ...
... Pa., Aug. 11 MEDRAD, INC., announced today,that ... System has received,U.S. Food and Drug Administration (FDA) ... The new Continuum Wireless MR Infusion System ... during a magnetic resonance (MR),procedure from both inside ...
... Tenn., Aug. 11 TeamHealth Inc.,s parent,company, Team ... the,second quarter ended June 30, 2008., The ... anesthesia,management services business line and substantially completed the ... of 2007. In accordance with,relevant accounting guidance, the ...
... Could Help Prevent,Another Blood Crisis, Allow More New Yorkers ... Has 35!!!, NEW YORK, Aug. 11 With ... New York City Councilman Eric Gioia,(D-Queens), Chairman of the ... New York Blood Center called for city,aid in expanding ...
... BEIJING, Aug. 11 /Xinhua-PRNewswire-FirstCall/ -- China Medical,Technologies, Inc. ... that it,intends to offer, subject to market and ... senior notes due 2013 and,American Depositary Shares, or ... underwriters of the notes offering pursuant to ADS,issuance ...
Cached Medicine News:Health News:Triax Pharmaceuticals Launches New Mid-Potency Corticosteroid Vehicle, Locoid Lotion 0.1% 2Health News:Triax Pharmaceuticals Launches New Mid-Potency Corticosteroid Vehicle, Locoid Lotion 0.1% 3Health News:Triax Pharmaceuticals Launches New Mid-Potency Corticosteroid Vehicle, Locoid Lotion 0.1% 4Health News:Rare case explains why some infected with HIV remain symptom free without antiretroviral drugs 2Health News:Rare case explains why some infected with HIV remain symptom free without antiretroviral drugs 3Health News:MEDRAD Receives FDA 510(k) Clearance for Wireless MR Infusion System 2Health News:MEDRAD Receives FDA 510(k) Clearance for Wireless MR Infusion System 3Health News:Team Finance LLC Announces Second Quarter 2008 Results 2Health News:Team Finance LLC Announces Second Quarter 2008 Results 3Health News:Team Finance LLC Announces Second Quarter 2008 Results 4Health News:Team Finance LLC Announces Second Quarter 2008 Results 5Health News:Team Finance LLC Announces Second Quarter 2008 Results 6Health News:Team Finance LLC Announces Second Quarter 2008 Results 7Health News:Team Finance LLC Announces Second Quarter 2008 Results 8Health News:Gioia & New York Blood Center Call for City Aid in Expansion of Mobile Blood Donor Coach Program 2Health News:Gioia & New York Blood Center Call for City Aid in Expansion of Mobile Blood Donor Coach Program 3Health News:China Medical Technologies Announces Concurrent Offerings of $150 Million of Convertible Senior Notes and Purchased ADSs Pursuant to ADS Issuance and Repurchase Agreements 2Health News:China Medical Technologies Announces Concurrent Offerings of $150 Million of Convertible Senior Notes and Purchased ADSs Pursuant to ADS Issuance and Repurchase Agreements 3Health News:China Medical Technologies Announces Concurrent Offerings of $150 Million of Convertible Senior Notes and Purchased ADSs Pursuant to ADS Issuance and Repurchase Agreements 4
(Date:8/29/2014)... Utah , Aug. 29, 2014  BC Technical, ... has acquired Polaris Medical Imaging, a leader in sales, ... This strategic acquisition allows BC Technical to continue to ... specifically within MR and CT modalities. ... service," said Mark Alvarez , president and CEO ...
(Date:8/29/2014)... -- Research and Markets has announced the ... & Pipeline Insight 2014" report to their offering. ... and eradicate the prevalence of cancer have achieved limited ... low specificity, safety and large number of side effects, ... solution. It has been discovered that peptides can be ...
(Date:8/29/2014)... August 29, 2014 According ... Market by Extraction type (SFE, Cold Pressed, Organic ... Care, Pharmaceutical, Food Supplements, Fragrance, & Others) - Global ... defines and segments the Amaranth Seed Oil Market ... size in terms of value. The Amaranth Seed ...
Breaking Medicine Technology:BC Technical Acquires Polaris Medical Imaging 2Global Peptide Cancer Therapeutics Market & Pipeline Insight 2014 2Amaranth Seed Oil Market worth $700.6 Million by 2019 2Amaranth Seed Oil Market worth $700.6 Million by 2019 3Amaranth Seed Oil Market worth $700.6 Million by 2019 4
... 4 Shire plc ... biopharmaceutical company, today announced that the US Food and ... information for its once-daily Attention Deficit Hyperactivity Disorder (ADHD) ... CII, to include supplemental data demonstrating significant improvement in ...
... , May 4 Kaiser Permanente, committed to improving the ... require suppliers to provide environmental data for $1 billion worth ... other facilities. , , , ... Scorecard is the first of its kind in health care. It will ...
Cached Medicine Technology:FDA Approves Labeling Change for Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII to Include Supplemental Data Demonstrating Significant Efficacy at Two Hours Through 14 Hours After Administration in Adults with ADHD 2FDA Approves Labeling Change for Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII to Include Supplemental Data Demonstrating Significant Efficacy at Two Hours Through 14 Hours After Administration in Adults with ADHD 3FDA Approves Labeling Change for Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII to Include Supplemental Data Demonstrating Significant Efficacy at Two Hours Through 14 Hours After Administration in Adults with ADHD 4FDA Approves Labeling Change for Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII to Include Supplemental Data Demonstrating Significant Efficacy at Two Hours Through 14 Hours After Administration in Adults with ADHD 5FDA Approves Labeling Change for Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII to Include Supplemental Data Demonstrating Significant Efficacy at Two Hours Through 14 Hours After Administration in Adults with ADHD 6FDA Approves Labeling Change for Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII to Include Supplemental Data Demonstrating Significant Efficacy at Two Hours Through 14 Hours After Administration in Adults with ADHD 7FDA Approves Labeling Change for Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII to Include Supplemental Data Demonstrating Significant Efficacy at Two Hours Through 14 Hours After Administration in Adults with ADHD 8Kaiser Permanente Launches Sustainability Scorecard for Medical Products 2Kaiser Permanente Launches Sustainability Scorecard for Medical Products 3
... IMMULITE 2000 assays are ... the IMMULITE 2000, a ... immunoassay analyzer. IMMULITE 2000 ... centralization, and a rapidly ...
... sulfate (DHEA-S) is the sulfate ester of ... enzymatic conversion of DHEA in adrenal and ... steroid secreted by the adrenal cortex, and ... biosynthesis. DHEA possesses relatively weak androgenic activity, ...
... sulfate ester of DHEA, derived from sulfated ... in adrenal and extradrenal tissues. DHEA is ... adrenal cortex, and is a precursor for ... weak androgenic activity, which for unsulfated DHEA ...
Inquire...
Medicine Products: